Chemo Plus Atezolizumab Shows Improved Survival Benefits in SCLC
This course discusses how the outcome of the combination regimen of chemotherapy and atezolizumab and subsequent treatment sequences upon patients with extensive-stage small call lung cancer (SCLC).
Click CE Information to start the course. Post Test and Evaluation must be completed to earn certificate of completion.